These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 23847984)
1. [Progressive renal diseases: recent advances in diagnosis and treatments. Topics: III. Recent topics; 3. Nephrosclerosis]. Shiraishi N; Tomita K Nihon Naika Gakkai Zasshi; 2013 May; 102(5):1180-9. PubMed ID: 23847984 [No Abstract] [Full Text] [Related]
2. [Hypertensive nephrosclerosis: an exhaustive diagnosis?]. Malatino L; Stancanelli B; Giannakakis C; Marcantoni C G Ital Nefrol; 2012; 29(6):650-4. PubMed ID: 23229662 [TBL] [Abstract][Full Text] [Related]
3. [Diagnosis of and therapy for renal hypertension]. Suzuki H; Kanno Y Nihon Naika Gakkai Zasshi; 2004 Mar; 93(3):488-92. PubMed ID: 15052808 [No Abstract] [Full Text] [Related]
4. Systemic and glomerular hypertension and progression of chronic renal disease: the dilemma of nephrosclerosis. Marín R; Gorostidi M; Fernández-Vega F; Alvarez-Navascués R Kidney Int Suppl; 2005 Dec; (99):S52-6. PubMed ID: 16336577 [TBL] [Abstract][Full Text] [Related]
5. Hypertension and nephrosclerosis: a reappraisal and a new theory of renal ischemia. Moore S Can Med Assoc J; 1967 Feb; 96(8):467-72. PubMed ID: 6020068 [TBL] [Abstract][Full Text] [Related]
6. Renal morphology in essential hypertension: analysis of 1177 unselected cases. Bohle A; Wehrmann M; Greschniok A; Junghans R Kidney Int Suppl; 1998 Sep; 67():S205-6. PubMed ID: 9736291 [TBL] [Abstract][Full Text] [Related]
7. [Clinical and pathological characteristics in patients with clinically presumed hypertensive nephrosclerosis]. Guo YS; Yuan WJ; Yu JP; Mei XB; Ye HY; Bian Q; Xu J Zhonghua Xin Xue Guan Bing Za Zhi; 2006 May; 34(5):391-5. PubMed ID: 16776947 [TBL] [Abstract][Full Text] [Related]
8. [Nephrosclerosis: current status]. Okamura M; Takeda T Nihon Rinsho; 1993 Aug; 51(8):2139-46. PubMed ID: 8411683 [TBL] [Abstract][Full Text] [Related]
9. [Nephrotic proteinuria in hypertensive nephrosclerosis: clinical and evolution characteristics]. Martín Alemany N; Almirall Daly J; Orellana Fernández R; Andreu X Med Clin (Barc); 2014 Nov; 143(9):392-4. PubMed ID: 24229808 [TBL] [Abstract][Full Text] [Related]
10. [Malignant nephrosclerosis]. Jancić-Zguricas M; Sindjić M; Laban A; Jovanović R Srp Arh Celok Lek; 1971; 99(4):257-63. PubMed ID: 5140933 [No Abstract] [Full Text] [Related]
11. Hyperuricemia as a Predictive Marker for Progression of Nephrosclerosis: Clinical Assessment of Prognostic Factors in Biopsy-Proven Arterial/Arteriolar Nephrosclerosis. Momoki K; Kataoka H; Moriyama T; Mochizuki T; Nitta K J Atheroscler Thromb; 2017 Jun; 24(6):630-642. PubMed ID: 27784849 [TBL] [Abstract][Full Text] [Related]
12. Nephroangiosclerosis: an update. Heras Benito M Hipertens Riesgo Vasc; 2023; 40(2):98-103. PubMed ID: 36050216 [TBL] [Abstract][Full Text] [Related]
16. [A case from practice (357)]. Heim M Praxis (Bern 1994); 1996 Sep; 85(38):1185-6. PubMed ID: 8927898 [No Abstract] [Full Text] [Related]
17. Recovery of renal function in patients with accelerated malignant nephrosclerosis on maintenance dialysis with management of blood pressure by captopril. Mourad G; Mimran A; Mion CM Nephron; 1985; 41(2):166-9. PubMed ID: 3900778 [TBL] [Abstract][Full Text] [Related]